Neurogene to Participate in Upcoming Investor Conferences
Business Wire•03/11/2026•07:30 ET
0
Key Highlights
- ➤Neurogene (NGNE) management to join Guggenheim Healthcare Innovation Conference November 10
- ➤Neurogene (NGNE) management to join Stifel Healthcare Conference November 11
- ➤Fireside chats and investor meetings scheduled at both conferences
- ➤NGN-401 advances as potential one-time Rett syndrome gene therapy treatment
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the following conferences:
Format: Management will participate in a fireside chat and investor meetings
Get started
Create a free account to read the full story.